Objectives: Inflammatory stimuli or mechanical stresses associated with hypothermic cardiopulmonary bypass could potentially impair cerebrovascular function, resulting in inadequate cerebral perfusion. We hypothesize that hypothermic cardiopulmonary bypass is associated with endothelial or vascular smooth muscle dysfunction and associated cerebral hypoperfusion. Therefore we studied the cerebrovascular response to endotheliumdependent vasodilator, acetylcholine, endothelium-independent nitric oxide donor, sodium nitroprusside, and vasoactive amine, serotonin, in newborn lambs undergoing hypothermic cardiopulmonary bypass (nasopharygeal temperature ‫؍‬ 18°C). Methods: Studies were performed on 13 newborn lambs equipped with a closed cranial window, allowing for direct visualization of surface pial arterioles. Six animals were studied while undergoing hypothermic cardiopulmonary bypass, whereas seven served as nonbypass, warm (37°C) controls. Pial arteriolar caliber (range ‫؍‬ 111 to 316 m diameter) was monitored using video microscopy. Results: Topical application of acetylcholine caused a dose-dependent increase in arteriolar diameter in the control group that was absent in animals undergoing hypothermic cardiopulmonary bypass. Hypothermic cardiopulmonary bypass did not alter the vasodilation in response to sodium nitroprusside. Furthermore, the contractile response to serotonin was fully expressed during hypothermic cardiopulmonary bypass. Conclusions: The specific loss of acetylcholine-induced vasodilation suggests endothelial cell dysfunction rather than impaired ability of vascular smooth muscle to respond to nitric oxide. It is speculated that loss of endothelium-dependent regulatory factors in the cerebral microcirculation during hypothermic cardiopulmonary bypass may enhance vasoconstriction, and impaired cerebrovascular function may be a basis for associated neurologic injury during or after hypothermic cardiopulmonary bypass. (J Thorac Cardiovasc Surg 1998; 115:1047-54) C erebral vasoparesis is believed to play a major role in causing cerebral injury in patients undergoing hypothermic cardiopulmonary bypass (HCPB).
C erebral vasoparesis is believed to play a major role in causing cerebral injury in patients undergoing hypothermic cardiopulmonary bypass (HCPB).
1, 2 During HCPB, autoregulation, usually preserved at temperatures greater than 22°C, is lost with profound hypothermia. This is an important consideration in infants and children in whom hypothermia in the range of 16°to 18°C is commonly achieved. In addition, reduced cerebral perfusion persistent after rewarming/reperfusion, "no-reflow," has been described in patients exposed to HCPB. 3, 4 These reports are suggestive of HCPB-associated derangements of cerebrovascular regulatory mechanisms. Nevertheless, the mechanism(s) by which HCPB induces cerebrovascular dysfunction is not known.
Studies of noncerebral arteries suggest that endothelium-dependent responses are specifically impaired in animals undergoing HCPB. [5] [6] [7] [8] However, similar data for the cerebral circulation are lacking because of the unique characteristics of the cerebrovascular bed, which make it difficult to study (i.e., its anatomic inaccessibility and the presence of the blood-brain barrier). 9 In this regard, the closed cranial window technique circumvents some of these problems, allowing direct assessment of function of cerebral resistance arterioles in vivo. This study used the closed cranial window technique to investigate specific functional aspects of the pial circulation in a neonatal lamb model undergoing HCPB, testing the hypothesis that HCPB is associated with impaired endothelial function in cerebral resistance vessels.
Methods
All animals received humane care in compliance with the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication No. 96-03, revised 1996), and the experimental protocol was approved by the Institutional Animal Care and Use Committee at the Allegheny University of the Health Sciences. Animals were preassigned to one of two groups as described below; in brief, one group would be studied while undergoing HCPB and the control group would be instrumented for HCPB but not connected to the bypass circuit. However, this selection was subject to hazard distribution (i.e., dependent on availability of perfusionists). Thus the selection of animals was not random but, nevertheless, there was no possibility of investigator bias in animal selection.
Animal preparation. Experiments were carried out on 13 newborn lambs 1 to 7 days of age. After induction of anesthesia (20 mg/kg ketamine ϩ 1 mg/kg diazepam, intramuscularly), a vertical incision was made in the groin and the femoral artery and vein were cannulated for continuous sedation (6 mg/kg per hour ketamine ϩ 0.15 mg/kg per hour diazepam) and intravenous fluid administration (5% glucose at 12 ml/hr). A vertical incision was made in the midline of the neck, and the right carotid artery was dissected free and encircled with 2-0 silk suture. A transverse incision was made between the second and third tracheal rings, and a 4 to 5 cm endotracheal tube was inserted and secured with umbilical tape ties. The animal was mechanically ventilated, positive end-expiratory pressure ϭ 3 to 4 cm water and inspired oxygen fraction ϭ 0.21 to 0.60 to ensure end-expired carbon dioxide was maintained between 35 and 40 mm Hg and arterial oxygen tension (PO 2 ) more than 200 mm Hg. Nasopharyngeal temperature was monitored using thermocouples in all cases and, in some preparations, a thermocouple was placed into the subdural space to monitor brain temperature. Arterial blood was sampled periodically from the femoral artery cannula and checked for pH, carbon dioxide tension (PCO 2 ), PO 2 , and electrolytes by use of conventional electrodes (NOVA Biomedical, Waltham, Mass.).
A cranial window was inserted over the left cerebral hemisphere (contralateral to the side of carotid artery cannulation) as previously described. 10 The animal's head was placed into a stereotaxic device and the scalp removed to expose the left parietal portion of the skull. A hole approximately 2 cm in diameter was made in the parietal plate, and the dura was carefully removed to expose the cerebral cortex. A cranial window was inserted into the hole, the edges were sealed with bone wax, and the device was cemented into place with dental acrylic as illustrated in Fig. 1 . The space under the window was filled with artificial cerebrospinal fluid (CSF) of the following composition (mmol/L): KCl (2.9), MgCl 2 (1.4), CaCl 2 (1.2), NaCl (132), NaHCO 3 (24.6), urea (6.7), and glucose (3.7), equilibrated with 6% carbon dioxide, 6% oxygen, at 37°C (control group) or 20°C (HCPB group). Pial arteries were visualized with a trinocular stereomicroscope (model M3Z, Wild, Heerbrugg, Switzerland) attached to a highresolution CDC video camera (model LX-450A, Optronics Engineering, Goleta, Calif.). The video image was recorded on video tape and intraluminal diameter (red cell column width) measured directly from the television screen after calibration with a stage micrometer. The pial arteries studied ranged in size from 111 to 316 m in diameter. One arteriole was studied in each animal.
After the cranial window had been secured, the animals were instrumented for cardiopulmonary bypass. After the administration of heparin (2 mg/kg, intravenously), the right carotid artery was cannulated with a 10F cannula. Through a right anterolateral thoracotomy in the third intercostal space, the pericardium was opened in front of the phrenic nerve and the right atrium was cannulated with an 18F cannula. In six experimental animals mechanical ventilation was discontinued and normothermic cardiopulmonary bypass was initiated at a flow rate of 100 to 150 ml/kg per minute. A membrane oxygenator (Minntech 400) was primed with 100 to 200 ml (depending on the size of the animal) of fresh sheep blood. Hematocrit was approximately 45% at initiation and was decreased as temperature decreased, achieving 21% to 22% at 18°C. No arterial filters were used. Systemic hypothermia was induced by core cooling to achieve 18°C nasopharyngeal temperature over a period of 30 minutes. Alpha-stat strategy was followed for acid-base management. Cardio- pulmonary bypass flow was adjusted to maintain a range of mean arterial pressure (Ն50 mm Hg) desired for evaluation of pial arteriolar reactivity during HCPB. The other seven animals were continued on mechanical ventilation and served as nonbypass warm controls. Experimental protocols. The pial arteriolar response to acetylcholine (ACh), an endothelium-dependent vasodilator, sodium nitroprusside (SNP), an endothelium-independent vasodilator, and serotonin, a vasoconstrictor amine, was evaluated as follows. Once the animal had achieved a steady state (i.e., stabilized blood pressure, blood gases, core temperature, and pial arteriolar diameter) the cortical surface under the window was suffused with artificial CSF (1 to 2 ml) by flushing into one port in the window and out another port, filling the space under the window without changing intracranial pressure. The ports were then closed and arteriolar diameter recorded. After 5 minutes, artificial CSF was replaced sequentially by increasing concentrations of ACh (10 Ϫ7 mol/L, 10
Ϫ6
mol/L, and 10 Ϫ5 mol/L in artificial CSF) for 5 minutes each. After this, the cortical surface was washed repeatedly (three to four times each 5 minutes) with artificial CSF. After recovery, dose-response curves to subsequent compounds (SNP or serotonin) were determined in similar fashion. The order by which the respective vasoactive compounds were administered in each animal was randomized. All three compounds were evaluated in three of the control animals and four of the HCPB animals.
Statistical analysis. All values are presented as mean Ϯ standard error of the mean For variables of interest (i.e., pial diameters and their percent changes) 95% confidence intervals were calculated for the individual groups and are presented as appropriate. The data were analyzed using two-way analysis of variance with one repeated measure (SigmaStat Statistical Software, Jandel Scientific, San Rafael, Calif.). The repeated measure was drug doses because these were administered sequentially to each animal. When the F value was significant, StudentNewman-Kuels test was used to test for significant differences between individual means.
Results
The control group and HCPB groups had a mean body weight of 6.4 Ϯ 0.5 kg and 7.3 Ϯ 1.0 kg, respectively. Table I compares the hemodynamic and blood gas status of control and HCPB groups at the time of the respective dose-response determinations to ACh, SNP, and serotonin. Mean arterial blood pressure, arterial pH, and arterial PCO 2 and PO 2 were not different between the two groups with the exception of PCO 2 , which was higher in the HCPB group during the serotonin administration. Fig. 2 shows two representative experiments from a control and a HCPB animal illustrating the pial artery diameter (top) and mean arterial blood pressure (bottom) during suffusion of ACh onto the cortical surface. Pial arteries typically exhibited a maximal response, in this case dilation in the control group, within 2 to 4 minutes of exposure to the test drug. As shown in this example, mean arteriolar blood pressure was not affected by the suffusion of drugs onto the cortical surface. Under these conditions (i.e., stable blood pressure and blood gases) changes in pial artery caliber can be attributed to the direct actions of the suffused compound.
The average changes in pial artery diameter in response to ACh, SNP, and serotonin are summarized in Table II and the relative response expressed as percent change is illustrated in Fig. 3 . Both ACh and SNP stimulated vasodilation, expressed as a dose-dependent increase in pial artery diameter, to a maximum of 18% Ϯ 6% and 19% Ϯ 7% at the highest concentration (10 -5 mol/L). In the control group (i.e., animals not undergoing bypass and at 37°C) ACh caused a dose-dependent increase in pial artery diameter from 163 Ϯ 22 m to a maximum of 190 Ϯ 18 m. When the data were compared in terms of absolute diameter, there was a significant interaction between group and drug effects, indicating that the response to ACh was dependent on the group treatment. When the response was normalized as percent of the initial diameter, the interaction term was no longer significant (p ϭ 0.171); however, there was a clear effect 
Values are mean Ϯ standard error of the mean. *Significantly different respective control group (p ϭ 0.028).
The
of group treatment (Fig. 3) . Thus the ACh-induced vasodilation was lost in the HCPB-treated group. In contrast, no significant group effect was noted for SNP, and serotonin stimulated a dose-dependent decrease in pial artery diameter (i.e., vasoconstriction) amounting to 26% Ϯ 4% decrease from baseline at the highest concentration (10 -5 mol/L). In summary, HCPB at 18°C significantly attenuated vasodilator response to ACh. However, no significant attenuation was noted for the vasodilator response to SNP or the vasoconstrictor response to serotonin (Fig. 3) . These negative findings are interpreted with caution, however, because of the low numbers. Nevertheless, we can say with confidence that both groups of animals responded potently and thus the response was fully expressed for both SNP and serotonin. This is in contrast to the findings for ACh.
Discussion
This study has used the closed cranial window preparation for analysis of cerebrovascular reactivity in vivo in a perinatal animal model undergoing HCPB. The advantage of this technique is that it allows direct visualization and continuous measurement of caliber of surface pial arterioles. As in this study, it provides a means for direct application of agents onto the perivascular surface, and thus reactivity of cerebral vessels can be studied without the complication of altered hemodynamic effects or possible influence of blood-brain barrier function that may occur with intravascular administration of experimental substances. Pial arterioles are major contributors of resistance to flow, and their responses are generally representative of the cerebral circulation as a whole. 9, 11 Active regulation of cerebrovascular resistance is achieved by changes in diameter at the level of resistance arterioles, where, as predicted by Poiseuille's law, resistance (R) is inversely proportional to the fourth power of the radius (r) of the artery (RϷ1/r 4 ). However, when applied in vivo, pial arteriolar diameter more closely approximates RϷ1/r 3 . 11 Nevertheless, it can be appreciated that even small changes in diameter will reflect significant changes in resistance to flow. The magnitude of the responses to ACh (8% to 19% dilation), SNP (5% to 23% dilation), and serotonin (12% to 27% constriction) are similar to what is noted in a number of species and comparable to the normal physiologic response to a 10 to 20 mm Hg increase in arterial PCO 2 . 9 Cerebrovascular dysfunction (i.e., loss of reactivity or "vasoparesis" during HCPB and/or vasospasm after HCPB) is believed to play a major role in the increased incidence of central nervous system injury associated with cardiac operation. 1 Our laboratory has preliminarily reported loss of pial arteriolar reactivity to blood pressure changes in neonatal lambs undergoing HCPB, 12 suggesting that impaired reactivity of these important cerebral resistance arterioles contributes to loss of cerebral blood flow autoregulation reported in human infants and children during HCPB. 2, 13 This study has attempted to characterize the reported cerebrovascular dysfunction as expressed in cerebral resistance arterioles during HCPB. Accordingly, this study examined the effect of HCPB on cerebrovascular reactivity to three distinct vasoactive stimuli of potential significance during HCPB, testing the hypothesis that loss of cerebrovascular function is specific to select physiologic or pathophysiologic stimuli whose expression is modulated by functional endothelium. ACh is widely used as a receptor-mediated stimulus of endothelium-dependent generation and release of classic endotheliumderived relaxing factor (EDRF). There is substantial evidence implicating nitric oxide (NO) or a closely related NO-containing species as the most potent EDRF, although clearly other EDRFs, especially arachidonic acid metabolites, have been identified. 14, 15 NO, which is synthesized from endogenous L-arginine by calcium-dependent activation of endothelial NO synthase, activates guanylate cyclase in vascular smooth muscle cells, stimulating cyclic guanosine monophosphate formation, which induces relaxation. 16 SNP is one of the nitrosovasodilators that generate NO directly and thus activates guanylate cyclase leading to vasodilation independent of endothelial NO synthase. Serotonin, a vasoactive amine, released by activated platelets is a potent vasoconstrictor of cerebral arteries by means of vascular 5-hydroxytryptamine 2 receptors. 17 However, 5-hydroxytryptamine receptors on the endothelium may also stimulate EDRF formation and modulate the contractile response to the amine. Clearly, EDRF/NO through its inhibitory influence on vascular smooth muscle, platelet activation, and adhesion properties is potentially important to the maintenance of cerebrovascular function during or after HCPB.
This study has shown that the vasodilator response to ACh was completely lost in those animals undergoing HCPB, whereas the vasodilator response to SNP was not affected. This indicates that the injury was at the level of the endothelium, whereas the capacity for vascular smooth muscle to relax in response to NO remained intact. At the same time the ability of the cerebral arteries to contract in response to serotonin was fully expressed during HCPB. It may also be concluded that cerebral "vasoparesis" is perhaps a misnomer or requires qualification when applied to HCPB because vasorelaxation as well as vasoconstriction to specific stimuli could be demonstrated. HCPB appears to cause selective loss of functional reactivity, and cerebral autoregulation and endothelium-depen- dent relaxation appear to be most readily demonstrable. Finally, we may conclude that cerebrovascular dysfunction during HCPB is expressed at the level of resistance arterioles visualized by the cranial window method, which may offer a new experimental approach to dissect the pathologic condition of HCPB.
Various pathologic conditions, including fluid percussion brain injury, acute hypertension, oxidant injury, air emboli, and ischemia/reperfusion, are associated with loss of relaxation response to ACh and other endothelium-dependent stimuli. Similarly, vascular pathophysiologic states associated with atherosclerosis, diabetes mellitus, immaturity, and aging often result in impaired endotheliumdependent reactivity. Similarly, studies of isolated femoral arteries and coronary and pulmonary circulation have shown loss of endothelium-dependent responses after HCPB, suggesting that reperfusion and/or rewarming may be associated with endothelium injury as well. [5] [6] [7] [8] However, the results of this study showed that endothelium-dependent relaxation to ACh was impaired during HCPB before rewarming/reperfusion and suggests that rewarming/ reperfusion is not necessarily the cause of the associated loss of the endothelium-dependent relaxation.
This study cannot otherwise identify specific factors that may have contributed to the impaired responses observed. One suggested mechanism is endothelial injury through gaseous microemboli that are frequently produced during cardiopulmonary bypass operations. 18, 19 However, in one study of femoral arteries, the magnitude of the functional impairment of endothelium-dependent relaxation was not correlated with the number of microemboli generated. 6 Another potential cause of impaired endothelium might result from the multitude of inflammatory mediators released during cardiopulmonary bypass, such as bradykinin, complement, cytokines, and reactive oxygen species, the latter of which is well known to interfere with endothelium-dependent relaxation. 20 Extracorporeal oxygenation also triggers platelet aggregation, and platelet aggregation itself may damage cerebrovascular endothelium. 21 Another significant factor altering cerebral reactivity may be hypothermia. The specific effect of deep hypothermia on cerebrovascular function is difficult to assess in vivo because of the profound decrease in cerebral oxygen consumption and associated decrease in cerebral blood flow. In isolated rat jugular vein, tissue cooling to 20°C attenuated the relaxation response to ACh and enhanced the contraction response to serotonin, showing that endothelial mechanisms do contribute to a coldinduced modification of reactivity. 22 Isolated cerebral arteries from newborn lambs in tissue bath Table II ). Error bars represent standard error of the mean; light shaded area represents 95% confidence intervals and dark shading represents their overlap. There was a significant difference between control and HCPB groups for acetylcholine (p ϭ 0.036), but no significant group effects were noted for sodium nitroprusside (p ϭ 0.268) or serotinin (p ϭ 0.304).
contracted to cooling from 37°C to 21°C, where contractile force varied inversely with bath temperature. 23 The cold-induced contraction appears to be mediated by protein tyrosine-dependent pathways. 24 SNP potently relaxed the cold-contracted cerebral arteries. These data suggest that impaired endothelium-dependent NO production may facilitate the contractile response to hypothermia. Furthermore, because cerebral vasoconstrictor responses were not impaired during HCPB, loss of NO production may set the stage for unmitigated vasoconstriction to vasoconstrictor amines, which may be especially potent in neonates. 23, 25 It is perhaps notable that NO formation is reportedly essential to the phenomenon of cerebral blood flow autoregulation in some species. For example, cerebral blood flow autoregulation is impaired by NO synthase inhibitors in rats and cats and the vasodilatation seen with breakthrough of autoregulation depends on release of NO or an NO donor. 26, 27 Furthermore, endothelium-dependent NO formation has been found to play a "permissive" role with respect to cerebrovascular reactivity to elevated arterial PCO 2 .
28 That is to say that certain vasodilator responses are expressed in the presence of basal levels of NO synthesis. In this role, rather than directly mediating vasodilation, NO modulates intracellular second messenger pathways, which permit expression of the normal vascular reactivity. This concept may provide a basis for understanding mechanisms by which impairment of endothelial function may influence cerebrovascular reactivity in a broader sense and thus contribute to selective cerebral vasoparesis.
In summary, this study has shown that HCPB impairs cerebral microvascular function (i.e., causes loss of endothelium-dependent vasodilation) but not nonspecific "vasoparesis" because select vasodilator and vasoconstrictor responses are preserved. It is likely that endothelial dysfunction coupled with preserved contractile capability may set the stage for enhanced cerebral vasoconstriction with an increased potential for cerebral hypoperfusion during or after the HCPB procedure.
